Yesterday, July 19, 2012, marked one year since Dr Hershel Toomim left our midst. His innovative work with HEG brain biofeedback lives on and will continue for as far as I can see. His use of blood flow measures as a direct biofeedback source (instead of a mere confirmation measurement) has made neurofeedback accessible to many who would not or could not do the more technically difficult EEG biofeedback. Interest grows amongst clinicians, schools and sports organizations, as well as businessmen who seek a solid way to measure attention. In this first year since Dr. Toomim’s passing, I have implemented more than 20 HEG biofeedback training centers in the Americas. This represents a growth of just over 30% from the year prior. My clients are generally clinicians attending populations for headache, attention and impulse control, mood and stress control and sensory gating issues.
Invariably within my prospective client’s decision process, I will be asked about the two technologies which both provide an HEG signal for feedback; the client wanting to know which is “better”. I don’t respond in a “better / worse” manner to my clients, and don’t intend to in this short article. Instead I will provide information from outside of the field of applied psychophysiology to shed light on the origins, research and other uses of these two technologies which were both “borrowed” from other industries for our use in benefit to the brain.